< previous page page_25 next page >

Page 25
2
Strategic Project Management at the Portfolio Level
Stephen Allport
GlaxoWellcome Research and Development
Greenford, Middlesex, England
3a2af372a540e460b69ba6aec2b32999.gif
I. Introduction
26
3a2af372a540e460b69ba6aec2b32999.gif
II. Why Bother with Portfolio Review and Analysis?
27
3a2af372a540e460b69ba6aec2b32999.gif
III. Overview of the Portfolio Review Process
28
3a2af372a540e460b69ba6aec2b32999.gif
IV. Portfolio Review Inputs
29
3a2af372a540e460b69ba6aec2b32999.gif
A. Research Potential
29
3a2af372a540e460b69ba6aec2b32999.gif
B. R&D Feasibility
30
3a2af372a540e460b69ba6aec2b32999.gif
C. Resources and Costs
30
3a2af372a540e460b69ba6aec2b32999.gif
D. Commercial Attractiveness
31
3a2af372a540e460b69ba6aec2b32999.gif
V. Data Gathering and Review
32
3a2af372a540e460b69ba6aec2b32999.gif
VI. Review Methodologies
34
3a2af372a540e460b69ba6aec2b32999.gif
A. Influence Diagrams
35
3a2af372a540e460b69ba6aec2b32999.gif
B. Decision Trees
35
3a2af372a540e460b69ba6aec2b32999.gif
C. Monte Carlo Simulation
36
3a2af372a540e460b69ba6aec2b32999.gif
D. Multiattribute Analysis
37
3a2af372a540e460b69ba6aec2b32999.gif
E. Option Pricing Analysis
38
3a2af372a540e460b69ba6aec2b32999.gif
VII. Results
39
3a2af372a540e460b69ba6aec2b32999.gif
A. Risk/Reward
39
3a2af372a540e460b69ba6aec2b32999.gif
B. Resources and Costs
43
3a2af372a540e460b69ba6aec2b32999.gif
C. Strategic Issues
45

 
< previous page page_25 next page >